HER2 assessment to define outcomes for breast cancer patients treated with neoadjuvant therapy

被引：0
|
作者：
Cheng, Huan [1 ]
Bai, Yalai [1 ]
Sikov, Willliam [2 ]
Sinclair, Natalie [2 ]
Abu-Khalaf, Maysa [1 ]
Harris, Lyndsay N. [1 ]
Rimm, David L. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Brown Univ, Providence, RI 02912 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-705
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
705
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia
    Rodriguez, Mauricio
    Gonzalez, Diego M.
    El-Sharkawy, Farah
    Castano, Mileny
    Madrid, Jorge
    BIOMEDICA, 2023, 43 (03): : 396 - 405
  • [2] Predictors of pathologic complete response in HER2 positive breast cancer patients treated with neoadjuvant targeted therapy
    Rosario, Mariela Huerta
    Sahoo, Sunati
    CANCER RESEARCH, 2020, 80 (04)
  • [3] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    BREAST, 2017, 32 : S18 - S18
  • [4] Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine Therapy
    Huang, Wei
    Tyburski, Haley
    Finkelman, Brian
    Turner, Bradley
    Weiss, Anna
    Dhakal, Ajay
    Skinner, Kristin
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2024, 104 (03) : S175 - S176
  • [5] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [6] The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
    Lillemoe, T. J.
    Susnik, B.
    Grimm, E.
    Kang, S-H L.
    Swenson, K. K.
    Krueger, J. L.
    Finkelstein, M. J.
    Tsai, M. L.
    CANCER RESEARCH, 2017, 77
  • [7] Impact of neoadjuvant HER2-directed therapy on HER2 status in breast cancer
    Manguso, Nicholas
    Johnson, Jeffrey
    Basho, Reva Kakkar
    McArthur, Heather L.
    Tanaka, Hisashi
    Giuliano, Armando E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [9] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [10] Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients
    Bo, Jiaqi
    Yu, Baohua
    Bi, Rui
    Xu, Xiaoli
    Cheng, Yufan
    Tu, Xi aoyu
    Bai, Qianming
    Yang, Wentao
    Shui, Ruohong
    CLINICAL BREAST CANCER, 2023, 23 (04) : 436 - 446
12345